Human Genome Epidemiology Literature Finder
Rare Diseases
Records 1 - 30 (of 1885 Records) |
Query Trace: Lung Adenocarcinoma[original query] |
---|
Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery. Cancers 2023 9 15 (17): . Hyunjong Lee, Yoon-La Choi, Hong Kwan Kim, Yong Soo Choi, Hojoong Kim, Myung-Ju Ahn, Hong Ryul Pyo, Joon Young Ch |
[Clinical characteristics and their influences on the survival of leptomeningeal metastasis derived from lung adenocarcinoma harboring epithelial growth factor receptor mutation]. Zhonghua yi xue za zhi 2023 9 103 (34): 2713-2719. A F Jiang, S S Zhou, Q Zhou, J Zhao, X P Li, R R Zhou, B |
Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands. JTO clinical and research reports 2023 9 4 (9): 100543. Anneloes L Noordhof, Esther M Swart, Ronald A M Damhuis, Lizza E L Hendriks, Peter W A Kunst, Mieke J Aarts, Wouter H van Geff |
Effects of concurrent TP53 mutations on the efficacy and prognosis of targeted therapy for advanced EGFR mutant lung adenocarcinoma. Cancer genetics 2023 9 278-279 62-70. Huiwen Qian, Chunqi Hou, Yi Zhang, Shundong Ji, Chongke Zhong, Juan Li, Qianqian Zhang, Jianan Huang, Chong Li, Cheng |
Prognostic value of genes related to cancer-associated fibroblasts in lung adenocarcinoma. Technology and health care : official journal of the European Society for Engineering and Medicine 2023 9 . Jigui Peng, Changjin He, Haiqiang Yan, Wang Zh |
Study on the application of percutaneous closed pleural brushing combined with cell block technique in the diagnosis of malignant pleural effusion. The clinical respiratory journal 2023 9 . Kang Wang, Xueting Hu, Yufang Chen, Xinglin Yi, Xianfeng Han, Duan Zhu, Bingjing Zhu, Hu L |
Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases. Brain sciences 2023 9 13 (9): . Yu Wang, Shenghong Wu, Jing Li, Xiaohua Liang, Xinli Zh |
Unveiling the metal mutation nexus: Exploring the genomic impacts of heavy metal exposure in lung adenocarcinoma and colorectal cancer. Journal of hazardous materials 2023 9 461 132590. Mengyuan Liu, Yuting Hong, Xiaohong Duan, Qiming Zhou, Jing Chen, Siyao Liu, Junyan Su, Li Han, Jiali Zhang, Beifang N |
Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies. Cancers 2023 9 15 (18): . Youngtaek Kim, Joon Yeon Hwang, Dong Kwon Kim, Kwangmin Na, Seul Lee, Sujeong Baek, Seong-San Kang, Seung Min Yang, Mi Hyun Kim, Heekyung Han, Chai Young Lee, Yu Jin Han, Min Hee Hong, Jii Bum Lee, Sun Min Lim, Byoung Chul Cho, Youngjoon Park, Kyoung-Ho P |
Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients. Cancers 2023 9 15 (18): . Lisa Rinaldi, Elena Guerini Rocco, Gianluca Spitaleri, Sara Raimondi, Ilaria Attili, Alberto Ranghiero, Giulio Cammarata, Marta Minotti, Giuliana Lo Presti, Francesca De Piano, Federica Bellerba, Gianluigi Funicelli, Stefania Volpe, Serena Mora, Cristiana Fodor, Cristiano Rampinelli, Massimo Barberis, Filippo De Marinis, Barbara Alicja Jereczek-Fossa, Roberto Orecchia, Stefania Rizzo, Francesca Bot |
Concordance of Abundance for Mutational EGFR and Co-Mutational TP53 with Efficacy of EGFR-TKI Treatment in Metastatic Patients with Non-Small-Cell Lung Cancer. Current oncology (Toronto, Ont.) 2023 9 30 (9): 8464-8476. Youping Wang, Hong Liu, Ningjuan Yu, Xueping Xia |
Computed Tomography-derived intratumoral and peritumoral radiomics in predicting EGFR mutation in lung adenocarcinoma. La Radiologia medica 2023 9 . Youlan Shang, Weidao Chen, Ge Li, Yijie Huang, Yisong Wang, Xiaoyan Kui, Ming Li, Hairong Zheng, Wei Zhao, Jun L |
Metastatic lung adenocarcinoma with BRCA2 mutation and longstanding disease control on olaparib, developing triple negative breast adenocarcinoma with additional BRCA2 reversion mutation: a case report. Journal of medical case reports 2023 9 17 (1): 407. Auro Del Giglio, Beatriz da Costa Aguiar Alves, André Márcio Murad, Fernando Luiz Affonso Fonse |
Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study. BMC pulmonary medicine 2024 4 24 (1): 167. Chao Mei, Tian Wang, Baoli Xu, Sanlan Wu, Xuelin Zhang, Yongning Lv, Yu Zhang, Zhaoqian Liu, Weijing Go |
Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma. Journal of translational medicine 2024 4 22 (1): 330. Long Zhang, Yajun Xiong, Jie Zhang, Yuying Feng, Aiguo |
Comprehensive analysis of lung adenocarcinoma: Unveiling differential gene expression, survival-linked genes, subtype stratification, and immune landscape implications. Environmental toxicology 2024 4 . Yong Xi, Liu Xi, Jian Tan, Chaoqun Yu, Weiyu Shen, Bentong |
Case report: Efficacy of icotinib treatment in lung adenocarcinoma with esophageal squamous cell carcinoma: a rare case of double primary malignant tumors. Frontiers in medicine 2024 4 11 1266062. Min Deng, Xiaoqing Li, Honghao Mu, Man Wei, Lan S |
ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation. BMC cancer 2024 4 24 (1): 452. Yue Huang, Dapeng Chen, Yi Bai, Yamin Zhang, Zhiwen Zheng, Qingfeng Fu, Bocun Yi, Yuchen Jiang, Zhihong Zhang, Jianqiang Z |
NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score. Heliyon 2024 4 10 (7): e28282. Liusheng Wu, Xiaofan Chen, Qi Zeng, Zelin Lai, Zhengyang Fan, Xin Ruan, Xiaoqiang Li, Jun Y |
Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 1 . Luoqi Weng, Yilun Xu, Yuhan Chen, Chengshui Chen, Qinqing Qian, Jie Pan, Huang |
Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib. Therapeutic advances in medical oncology 2024 1 16 17588359231220606. Jia-Jun Wu, Jeng-Sen Tseng, Zhe-Rong Zheng, Cheng-Hsiang Chu, Kun-Chieh Chen, Mong-Wei Lin, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Tsung-Ying Yang, Sung-Liang Yu, Jin-Shing Chen, Chao-Chi Ho, Gee-Chen Cha |
Using Multi-phase CT Radiomics Features to Predict EGFR Mutation Status in Lung Adenocarcinoma Patients. Academic radiology 2024 1 . Guojin Zhang, Qiong Man, Lan Shang, Jing Zhang, Yuntai Cao, Shenglin Li, Rong Qian, Jialiang Ren, Hong Pu, Junlin Zhou, Zhuoli Zhang, Weifang Ko |
Clinicopathological significances of cribriform pattern in lung adenocarcinoma. Pathology, research and practice 2024 1 253 155035. Jung-Soo Pyo, Byoung-Hoon Lee, Kyueng-Whan Min, Nae Yu K |
Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes. BMC cancer 2024 1 24 (1): 28. Fang Zhou, Meng Wang, Zheng Wang, Wei Li, Xike |
Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma. Experimental biology and medicine (Maywood, N.J.) 2024 1 15353702231214266. Sha Yang, Ke Li, Jiqin Zhang, Jian Liu, Lin Liu, Ying Tan, Chuan |
The detection of PD-L1 expression on liquid-based cytology in pleural effusion of lung adenocarcinoma and its prognostic evaluation: Between paired liquid-based cytology and cell block samples. Diagnostic cytopathology 2024 1 . Haiyue Ma, Jia Jia, Zihan Sun, Xiaoyue Xiao, Shuo Liang, Linlin Zhao, Zhihui Zha |
The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma. Journal of cancer research and therapeutics 2024 1 . Mukremin Uysal, Ismail Beypinar, Murat Ar |
Obesity shapes selection for driver mutations in cancer. medRxiv : the preprint server for health sciences 2024 1 . Cerise Tang, Venise Jan Castillon, Michele Waters, Chris Fong, Tricia Park, Sonia Boscenco, Susie Kim, Nikolaus Schultz, Irina Ostrovnaya, Alexander Gusev, Justin Jee, Ed Rezn |
KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges. Pathology oncology research : POR 2024 1 29 1611580. Judit Moldvay, József Tím |
Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma. BMC cancer 2024 1 24 (1): 63. Chao Chen, Haozhen Liu, Yanling Li, Qumiao Xu, Jixian L |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: